| General Information | |||
|---|---|---|---|
| Term | thiamine-responsive megaloblastic anemia syndrome | ID (Ontology) | DOID:0090117 (Human Disease) |
| Definition | A syndrome that is characterized by megaloblastic anemia, non-type I diabetes mellitus, and sensorineural deafness where the anemia and sometimes diabetes is repsonsive to high doses of thiamine, and that has_material_basis_in homozygous mutation in the solute carrier family 19 member 2 (SLC19A2) gene on chromosome 1q24. | ||
| Also Known As | "Rogers syndrome" ; "thiamine metabolism dysfunction syndrome 1" ; "thiamine-responsive anaemia syndrome" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
autosomal genetic disease |__autosomal recessive disease__ disease | |__syndrome_____________________| thiamine-responsive megaloblastic anemia syndrome 1 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a |
autosomal recessive disease syndrome |
||
| Part of | |||
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
External Crossreferences & Linkouts
|
|||
|
GARD:9210 MESH:C536510 MIM:249270 ORDO:498277 SNOMEDCT_US_2023_03_01:237617006 UMLS_CUI:C0342287 |
|||